Lilly’s COVID-19 treatment receives emergency-use approval from FDA, stock jumps 3%
November 09, 2020 at 19:19 PM EST
Eli Lilly & Co.'s COVID-19 antibody treatment was approved for emergency use by the Food and Drug Administration on Monday, and Lilly shares jumped more than 3% in after-hours trading.
